Listed

Turning Point Brands, Inc.: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 1, 2019 and accepted by EDGAR at May 1, 2019, 16:24 ET.

Share

Management's discussion and analysis

As filed, 26,867 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion of the historical financial condition and results of operations in conjunction with our historical consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”

The following discussion relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.

Organizational Structure

We, Turning Point Brands, Inc., are a holding company which owns North Atlantic Trading Company, Inc. (“NATC”), and its subsidiaries National Tobacco Company, L.P. (“NTC”), National Tobacco Finance, LLC (“NTFLLC”), North Atlantic Operating Company, Inc. (“NAOC”), North Atlantic Cigarette Company, Inc. (“NACC”), and RBJ Sales, Inc. (“RBJ”), and Turning Point Brands, LLC (“TPLLC”), and its subsidiaries Intrepid Brands, LLC (“Intrepid”), Vapor Beast, LLC (“VaporBeast”, f/k/a Smoke Free Technologies, Inc.), Vapor Shark, LLC, and its subsidiaries (collectively, “Vapor Shark”, f/k/a The Hand Media), Vapor Acquisitions Company, LLC (“Vapor Supply”), Vapor Finance, LLC (“VFIN”), International Vapor Group, LLC and its subsidiaries (collectively, “IVG”), and Nu-X Ventures, LLC (“Nu-X”).

Overview

We are a leading independent provider of Other Tobacco Products (“OTP”) in the U.S. We sell a wide range of products across the OTP spectrum including moist snuff tobacco (“MST”), loose leaf chewing tobacco, premium cigarette papers, make-your-own (“MYO”) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products; however, we do not sell cigarettes. We estimate the OTP industry generated approximately $11 billion in manufacturer revenue in 2018. In contrast to manufactured cigarettes, which have been experiencing declining volumes for decades based on data published by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”), the OTP industry is demonstrating increased consumer appeal with low- to mid-single digit consumer unit growth as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and informatics company. Under the leadership of a senior management team with an average of 23 years of experience in the tobacco industry, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.

Products

We operate in three segments: Smokeless products, Smoking products and NewGen products. In our Smokeless products segment we (i) manufacture and market moist snuff and (ii) contract for and market loose leaf chewing tobacco products. In our Smoking products segment, we (i) market and distribute cigarette papers, tubes, and related products; (ii) market and distribute finished cigars and MYO cigar wraps; and (iii) process, package, market, and distribute traditional pipe tobaccos. In our NewGen products segment, we (i) market and distribute e-cigarettes, e-liquids, vaporizers, and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of vaping and CBD related products to non-traditional retail via VaporBeast, Vapor Shark, Vapor Supply, and IVG; and (iii) distribute a wide assortment of vaping and CBD related products to individual consumers via Vapor Shark, Vapor World, and VaporFi branded retail outlets in addition to online platforms. Our portfolio of brands includes some of the most widely recognized names in the OTP industry such as Stoker’s® in the Smokeless segment, Zig-Zag® in the Smoking segment, and VaporBeast® and VaporFi® in the NewGen segment.

Operations

Our core tobacco business (Smokeless and Smoking segments) primarily generates revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of VaporBeast in the fourth quarter of 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisitions of Vapor Shark in the second quarter of 2017 and Vapor Supply in the second quarter of 2018 further expanded our selling network by allowing us to directly reach ultimate consumers through Vapor Shark and Vapor World branded retail outlets, respectively. Our acquisition of IVG in the third quarter of 2018 enhanced our business-to-consumer revenue stream with the addition of Vapor-Fi branded retail outlets accompanying a robust online platform headlined by VaporFi.com and DirectVapor.com. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. Approximately 85% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists of our moist snuff tobacco operations located in Dresden, Tennessee, and Louisville, Kentucky; the packaging of our pipe tobacco in Louisville, Kentucky; and the proprietary e-liquids operations located in Louisville, Kentucky, and Miami, Florida. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense and other expenses.

Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

  • Our ability to further penetrate markets with our existing products;
  • Our ability to introduce new products and product lines that complement our core business;
  • Decreasing interest in some tobacco products among consumers;
  • Price sensitivity in our end-markets;
  • Marketing and promotional initiatives, which cause variability in our results;
  • General economic conditions, including consumer access to disposable income;
  • Cost and increasing regulation of promotional and advertising activities;
  • Cost of complying with regulation, including newly passed “deeming regulations”;
  • Counterfeit and other illegal products in our end-markets;
  • Currency fluctuations;
  • Our ability to identify attractive acquisition opportunities in OTP; and
  • Our ability to integrate acquisitions.

Recent Developments

VMR

We engaged in discussions and mediation with VMR Products LLC (“VMR”), which was acquired in 2018. Pursuant to a Distribution and Supply agreement (“VMR Agreement”), VMR was providing us with V2 e-cigarettes for the exclusive distribution in bricks-and-mortar stores in the United States. Under the terms of the VMR Agreement, in the event of termination following a change in control, the acquirer was required to make a payment to us under a formula designed to provide us with a fair share of the value created by our performance under the VMR Agreement. The discussions have been completed and we received $6.7 million in April 2019 to settle the issue. Net of legal costs and reserves for anticipated future returns associated with the discontinuance, we expect to record a $5.5 million gain in the second quarter.

Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2018 Annual Report on Form 10-K.

Recent Accounting Pronouncements

Refer to Note 2 of Notes to Consolidated Financial Statements included in this Quarterly Report for a description of recently issued accounting pronouncements, including those recently adopted.

Results of Operations

Comparison of the Three Months Ended March 31, 2019, to the Three Months Ended March 31, 2018

The table and discussion set forth below displays our consolidated results of operations (in thousands):

Consolidated Results of Operations Data: Net sales Three Months Ended March 31, 2019 2018 % Change
Smokeless products $22,544 $20,747 8.7%
Smoking products 25,519 26,996 -5.5%
NewGen products 43,565 26,199 66.3%
Total net sales 91,628 73,942 23.9%
Cost of sales 51,164 42,133 21.4%
Gross profit
Smokeless products 12,073 10,993 9.8%
Smoking products 13,484 13,164 2.4%
NewGen products 14,907 7,652 94.8%
Total gross profit 40,464 31,809 27.2%
Selling, general, and administrative expenses 28,429 22,068 28.8%
Operating income 12,035 9,741 23.5%
Interest expense, net 3,856 3,654 5.5%
Investment Income (144) (95) 51.6%
Loss on extinguishment of debt - 2,384 -100.0%
Net periodic benefit income, excluding service cost (11) (43) -74.4%
Income before income taxes 8,334 3,841 117.0%
Income tax expense 1,774 809 119.3%
Consolidated net income $6,560 $3,032 116.4%

Net Sales: For the three months ended March 31, 2019, consolidated net sales increased to $91.6 million from $73.9 million for the three months ended March 31, 2018, an increase of $17.7 million or 23.9%. The increase in net sales was primarily driven by volume growth in NewGen which includes the addition of three months of IVG and Vapor Supply sales in 2019.

For the three months ended March 31, 2019, net sales in the Smokeless products segment increased to $22.5 million from $20.7 million for the three months ended March 31, 2018, an increase of $1.8 million or 8.7%. For the three months ended March 31, 2019, volume increased 4.8% and price/mix increased 3.9%. The increase in net sales was primarily driven by the continuing double-digit volume growth of Stoker’s® MST partially offset by declining sales in chewing tobacco, largely attributable to long-term segment erosion, and a continuing shift to lower price products.

For the three months ended March 31, 2019, net sales in the Smoking products segment decreased to $25.5 million from $27.0 million for the three months ended March 31, 2018, a decrease of $1.5 million or 5.5%. For the three months ended March 31, 2019, volume decreased 8.4% and price/mix increased 2.9%. The net sales decline is attributable to delayed Canadian paper orders as a result of the packaging regulations and declining sales in the low-margin cigars business.

For the three months ended March 31, 2019, net sales in the NewGen products segment increased to $43.6 million from $26.2 million for the three months ended March 31, 2018, an increase of $17.4 million or 66.3%. The increase in net sales was primarily driven by continued VaporBeast momentum, and three months of IVG and Vapor Supply net sales.

Gross Profit: For the three months ended March 31, 2019, consolidated gross profit increased to $40.5 million from $31.8 million for the three months ended March 31, 2018, an increase of $8.7 million or 27.2%. Gross profit as a percentage of revenue increased to 44.2% for the three months ended March 31, 2019, from 43.0% for the three months ended March 31, 2018.

For the three months ended March 31, 2019, gross profit in the Smokeless products segment increased to $12.1 million from $11.0 million for the three months ended March 31, 2018, an increase of $1.1 million or 9.8%. Gross profit as a percentage of net sales increased to 53.6% of net sales for the three months ended March 31, 2019, from 53.0% of net sales for the three months ended March 31, 2018, primarily as a result of product mix.

For the three months ended March 31, 2019, gross profit in the Smoking products segment increased to $13.5 million from $13.2 million for the three months ended March 31, 2018, an increase of $0.3 million or 2.4%. Gross profit as a percentage of net sales increased to 52.8% of net sales for the three months ended March 31, 2019, from 48.8% of net sales for the three months ended March 31, 2018, as a result of a continued decline in the low margin cigar business. For the three months ended March 31, 2019 cigar sales were $1.1 million compared to $1.6 million for the three months ended March 31, 2018.

For the three months ended March 31, 2019, gross profit in the NewGen products segment increased to $14.9 million from $7.7 million for the three months ended March 31, 2018, an increase of $7.3 million or 94.8%. Gross profit as a percentage of net sales increased to 34.2% of net sales for the three months ended March 31, 2019, from 29.2% of net sales for the three months ended March 31, 2018, primarily as a result of the addition of IVG, a business-to-consumer operation which generally has higher margins.

Selling, General, and Administrative Expenses: For the three months ended March 31, 2019, selling, general, and administrative expenses increased to $28.4 million from $22.1 million for the three months ended March 31, 2018, an increase of $6.4 million or 28.8%. Selling, general and administrative expenses included $5.9 million of expense relating to the inclusion of Vapor Supply and IVG, $0.9 million of transaction costs including an earnout for IVG management, $0.5 million of severance related expenses for organizational changes, $0.5 million of duplicative warehouse expenses associated with consolidating VaporBeast operations into the Louisville facility and $0.4 million of new product launch costs for Nu-X products.

Interest Expense, net: For the three months ended March 31, 2019, interest expense increased to $3.9 million from $3.7 million for the three months ended March 31, 2018, as a result of higher outstanding balance on our revolver and higher interest rates.

Investment Income: Investment income relating to investment of the MSA escrow deposits was approximately $0.1 million for the three months ended March 31, 2019 and 2018.

Loss on extinguishment of debt: For the three months ended March 31, 2019, we had no loss on extinguishment of debt. For the three months ended March 31, 2018, loss on extinguishment of debt was $2.4 million as the result of refinancing our credit facility during the period.

Income Tax Expense: Our income tax expense of $1.8 million was 21.3% of income before income taxes for the three months ended March 31, 2019 compared to 21.1% for the three months ended March 31, 2018.

Consolidated Net Income: Due to the factors described above, consolidated net income for the three months ended March 31, 2019 and 2018, was $6.6 million and $3.0 million, respectively.

EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our credit agreements contain financial covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of ongoing operating performance.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

Three Months Ended March 31, 2019 2018
Consolidated net income $6,560 $3,032
Add:
Interest expense, net 3,856 3,654
Loss on extinguishment of debt - 2,384
Income tax expense 1,774 809
Depreciation expense 531 560
Amortization expense 359 175
EBITDA $13,080 $10,614
Components of Adjusted EBITDA
LIFO adjustment (a) (24) (57)
Pension/postretirement expense (income) (b) 16 (17)
Stock options, restricted stock, and incentives expense (c) 715 197
Foreign exchange hedging (d) (71) 46
Transactional expenses and strategic initiatives (e) 910 599
New product launch costs (f) 442 682
Product line rationalizations (g) - 1,008
Warehouse reorganization (h) 508 -
Severance charges and organizational development (i) 496 636
Adjusted EBITDA $16,072 $13,708

(a) Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting.

(b) Represents our non-cash pension/postretirement expense.

(c) Represents non-cash stock options, restricted stock and incentives expense.

(d) Represents non-cash gain and loss stemming from our foreign exchange hedging activities.

(e) Represents the fees incurred for transaction expenses and strategic initiatives.

(f) Represents product launch costs of our new product lines.

(g) Represents costs associated with discontinued products related to product line rationalization.

(h) Represents costs associated with consolidating warehouses.

(i) Represents costs associated with departmental restructuring, including severance.

Liquidity and Capital Reserves

Our principal uses for cash are working capital, debt service, and capital expenditures. We believe our cash flows from operations and borrowing availability under our 2018 Revolving Credit Facility are adequate to satisfy our operating cash requirements for the foreseeable future.

Our working capital, which we define as current assets less current liabilities, decreased $1.0 million to $47.1 million at March 31, 2019, compared with $48.1 million at December 31, 2018. The decrease in working capital is primarily due to the IVG Note Payable becoming current.

(in thousands)

As of March 31, 2019 December 31, 2018
Current assets $108,621 $111,854
Current liabilities 61,489 63,766
Working capital $47,132 $48,088

Cash Flows from Operating Activities

For the three months ended March 31, 2019, net cash provided by operating activities was $14.0 million compared to net cash provided by operating activities of $8.4 million for the three months ended March 31, 2018, an increase of $5.6 million, primarily due to changes in working capital accounts.

Cash Flows from Investing Activities

For the three months ended March 31, 2019, net cash provided by investing activities was $0.8 million compared to net cash used in investing activities of $0.9 million for the three months ended March 31, 2018, an increase of $1.7 million, primarily due to MSA funds shifting from investments to cash.

Cash Flows from Financing Activities

For the three months ended March 31, 2019, net cash used in financing activities was $14.7 million compared to net cash used in financing activities of $6.9 million for the three months ended March 31, 2018, an increase of $7.8 million, primarily due to payments on our 2018 Revolving Credit Facility, as well as the payment of financing costs in 2018, which did not occur in 2019.

Dividends

On November 9, 2017, our Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of $0.04 per common share was paid on December 15, 2017, to shareholders of record at the close of business on November 27, 2017. The most recent dividend of $0.045 per common share was paid on April 12, 2019, to shareholders of record at the close of business on March 22, 2019.

Long-Term Debt

As of March 31, 2019, we were in compliance with the financial and restrictive covenants of the 2018 Credit Facility. The following table provides outstanding balances of our debt instruments.

March 31, 2019 December 31, 2018
2018 Revolving Credit Facility $14,000 $26,000
2018 First Lien Term Loan 152,000 154,000
2018 Second Lien Term Loan 40,000 40,000
Note payable - IVG 4,000 4,000
Total notes payable and long-term debt 210,000 224,000
Less deferred finance charges (3,100) (3,285)
Less revolving credit facility (14,000) (26,000)
Less current maturities (12,000) (8,000)
$180,900 $186,715

33

2018 Credit Facility

The 2018 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2018 Credit Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2018 Credit Facility, restrict our ability: (i) to pledge assets, (ii) to incur additional indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments. Refer to Note 18 of Notes to Consolidated Financial Statements for further information regarding dividend restrictions.

2018 First Lien Credit Facility: The 2018 First Lien Term Loan and the 2018 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.75% to 3.50% based on our senior leverage ratio. The 2018 First Lien Term Loan has quarterly required payments of $2.0 million beginning June 30, 2018, increasing to $3.0 million on June 30, 2020, and increasing to $4.0 million on June 30, 2022. The 2018 First Lien Credit Facility has a maturity date of March 7, 2023. The 2018 First Lien Term Loan is secured by a first priority lien on substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of our capital stock, other than certain excluded assets (the “Collateral”). The 2018 First Lien Credit Facility contains certain financial covenants including maximum senior leverage ratio of 3.50x with step-downs to 3.00x, a maximum total leverage ratio of 4.50x with step-downs to 4.00x, and a minimum fixed charge coverage ratio of 1.20x. The weighted average interest rate of the 2018 First Lien Term Loan was 5.75% at March 31, 2019. The weighted average interest rate of the 2018 Revolving Credit Facility was 6.61% at March 31, 2019. At March 31, 2019, we had $14.0 million of borrowings outstanding under the 2018 Revolving Credit Facility. The $36.0 million unused portion of the 2018 Revolving Credit Facility is reduced by a $1.3 million letter of credit with Fifth Third Bank, resulting in $34.7 million of availability under the 2018 Revolving Credit Facility at March 31, 2019.

2018 Second Lien Credit Facility: The 2018 Second Lien Credit Facility bears interest at a rate of LIBOR plus 7.00% and has a maturity date of March 7, 2024. The 2018 Second Lien Term Loan is secured by a second priority interest in the Collateral and is guaranteed by the same entities as the 2018 First Lien Term Loan. The 2018 Second Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 3.75x with step-downs to 3.50x, a maximum total leverage ratio of 4.75x with step-downs to 4.50x, and a minimum fixed charge coverage ratio of 1.10x. The weighted average interest rate of the 2018 Second Lien Term Loan was 9.48% at March 31, 2019.

Note Payable – IVG

In September 2018, we issued a note payable to IVG’s former shareholders (“IVG Note”). The IVG Note is $4.0 million principal with 6.0% interest compounding annually and matures on March 5, 2020. All principal and accrued and unpaid interest under the IVG Note is subject to indemnification obligations of the sellers pursuant to the International Vapor Group Stock Purchase Agreement dated as of September 5, 2018.

Off-balance Sheet Arrangements

During the first quarter of 2019 we did not execute any forward contracts. During 2018 the Company executed various forward contracts, none of which met hedge accounting requirements, for the purchase of €14.5 million with maturity dates ranging from March 2018 to January 2019. At March 31, 2019, and December 31, 2018, we had forward contracts for the purchase of €0.0 million and €1.5 million, respectively.

Inflation

We believe that any effect of inflation at current levels will be minimal. Historically, we have been able to increase prices at a rate equal to or greater than that of inflation and believe that we will continue to be able to do so for the foreseeable future. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement with regard to our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

Market risk

As filed, 1,737 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Foreign Currency Sensitivity

Although we engaged in hedging inventory purchases during the three months ended March 31, 2019, there have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2018 Annual Report on Form 10-K, during the period. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2018 Annual Report on Form 10-K filed with the SEC.

Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our 2018 Annual Report on Form 10-K, during the three months ended March 31, 2019. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2018 Annual Report on Form 10-K filed with the SEC.

Interest Rate Sensitivity

Our March 2018 refinancing resulted in all of our long-term debt instruments having variable interest rates that fluctuate with market rates. To reduce the volatility of future cash flows, we entered into interest rate swap agreements with lenders under the 2018 Credit Facility in March 2018. At March 31, 2019, $70 million of our outstanding long-term debt carrying variable rates is covered by the interest rate swap agreements and, thus, effectively bears interest at a fixed rate. We believe the effect, if any, of reasonably possible near-term changes in interest rates on our consolidated financial position, results of operations, or cash flows would not be significant. A 1% increase in the interest rate would change pre-tax income by approximately $1.4 million per year. Refer to Note 4 of Notes to Consolidated Financial Statements located at Part I, Item 1, for additional information regarding the interest rate swaps.

Controls and procedures

As filed, 1,321 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Act”)) as of March 31, 2019. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Act is: (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.

There have been no changes in the Company’s internal control over financial reporting during the most recent fiscal quarter which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 289 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2018 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2018 Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$91.6mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2019-01-01 to 2019-03-31$51.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-01-01 to 2019-03-31$40.5mus-gaap:GrossProfit
Selling, general and administrative3 months2019-01-01 to 2019-03-31$28.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-01-01 to 2019-03-31$12.0mus-gaap:OperatingIncomeLoss
Income tax3 months2019-01-01 to 2019-03-31$1.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-01-01 to 2019-03-31$6.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31$0.33us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-01-01 to 2019-03-31$0.34us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-01-01 to 2019-03-3120,045,964 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2019-01-01 to 2019-03-31$14.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2019-01-01 to 2019-03-31$886.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2019-01-01 to 2019-03-31$880.0kus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2019-03-31$1.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$108.6mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$347.5mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$61.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$258.7mus-gaap:Liabilities
Long-term debtAt period end2019-03-31$180.9mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-03-31$12.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2019-03-31$88.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001140361-19-008162. Last ingested by Listed: Nov 10, 2026, 02:39 ET. Listed shows no prices and gives no investment advice.